Seek Returns

ARGX vs. TMO: argenx vs. Thermo Fisher Scientific Stock Comparison

How do argenx (ARGX) and Thermo Fisher Scientific (TMO) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

argenx (ARGX) and Thermo Fisher Scientific (TMO) both fall under the Pharmaceuticals, Biotechnology & Life Sciences industry group, but ARGX is classified in Biotechnology while TMO is classified in Life Sciences Tools & Services.

Thermo Fisher Scientific (TMO) trades as ordinary local shares, while argenx (ARGX) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Company profile comparison for argenx (ARGX) and Thermo Fisher Scientific (TMO)
Profile ItemARGXTMO
Nameargenx SE American Depositary ReceiptThermo Fisher Scientific Inc.
Country/RegionNetherlandsUnited States
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnologyLife Sciences Tools & Services
GICS Sub-IndustryBiotechnologyLife Sciences Tools & Services
Market Capitalization58.31 billion USD257.42 billion USD
CurrencyUSDUSD
ExchangeNasdaqNYSE
Listing DateMay 18, 2017March 17, 1980
Security TypeADRCommon Stock

Price Performance

Cumulative Growth

ARGX
TMO
GSPC
Loading price history…
argenx (ARGX) vs. Thermo Fisher Scientific (TMO), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for argenx (ARGX) and Thermo Fisher Scientific (TMO). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for argenx (ARGX) and Thermo Fisher Scientific (TMO). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for argenx (ARGX) and Thermo Fisher Scientific (TMO)
MetricARGXTMO
Total Return (1Y)11.91%24.62%
Total Return (3Y, Annualized)25.68%17.34%
Total Return (5Y, Annualized)24.22%3.11%

Risk Profile

Drawdown History

ARGX
TMO
GSPC
Loading price history…
argenx (ARGX) vs. Thermo Fisher Scientific (TMO), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for argenx (ARGX) and Thermo Fisher Scientific (TMO). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for argenx (ARGX) and Thermo Fisher Scientific (TMO)
MetricARGXTMO
Volatility (1Y, Annualized)37.87%29.96%
Beta (5Y)0.450.83
Max Drawdown (5Y)-38.20%-40.95%
Avg. Volume (3M)359.84K2.10M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
ARGX and TMO are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for argenx (ARGX) and Thermo Fisher Scientific (TMO)
MetricARGXTMO
Sharpe Ratio (1Y)0.200.68
Sortino Ratio (1Y)0.311.02

Profitability

ROE (TTM)

Capital efficiency shows on one side only: Thermo Fisher Scientific (TMO) earns 13.38% on shareholders’ equity, ranked against its industry; argenx (ARGX) has no ROE this period.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
ARGX
--

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

13.38%

Max
109.18%
TMO
13.38%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Loading chart…
argenx (ARGX) vs. Thermo Fisher Scientific (TMO): ARGX does not report ROE, so it has no value marker; TMO is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Net Margin (TTM)

argenx (ARGX) at 31.73% keeps the most of each sales dollar — above its industry’s net margin range — and Thermo Fisher Scientific (TMO) at 14.94% also retains a top-quartile share.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

31.73%

ARGX
31.73%
Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

14.94%

Max
18.05%
TMO
14.94%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Loading chart…
argenx (ARGX) vs. Thermo Fisher Scientific (TMO): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Both argenx (ARGX) at 36.27% and Thermo Fisher Scientific (TMO) at 20.19% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

36.27%

Max
83.12%
ARGX
36.27%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

20.19%

Max
83.12%
TMO
20.19%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
argenx (ARGX) vs. Thermo Fisher Scientific (TMO): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for argenx (ARGX) and Thermo Fisher Scientific (TMO)
MetricARGXTMO
ROE (TTM)--13.38%
ROA (TTM)--5.19%
Net Margin (TTM)31.73%14.94%
Operating Margin (TTM)36.27%20.19%
Gross Margin (TTM)59.84%41.26%

Growth

Revenue Growth

argenx (ARGX) at 89.64% sits in the top revenue growth quartile, while Thermo Fisher Scientific (TMO) at 3.91% is closer to the peer norm — faster top-line expansion for ARGX.

Loading chart…
argenx (ARGX) vs. Thermo Fisher Scientific (TMO): A comparison of their Revenue Growth across different time periods.

EPS Growth

Both argenx (ARGX) at 53.13% and Thermo Fisher Scientific (TMO) at 7.32% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

Loading chart…
argenx (ARGX) vs. Thermo Fisher Scientific (TMO): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for argenx (ARGX) and Thermo Fisher Scientific (TMO)
MetricARGXTMO
Revenue Growth (YoY)89.64%3.91%
Revenue Growth (3Y CAGR)116.25%-0.27%
EPS Growth (YoY)53.13%7.32%
EPS Growth (3Y CAGR)--0.21%

Financial Strength

Current Ratio (MRQ)

Short-term liquidity can only be read on one side of this pairing: Thermo Fisher Scientific (TMO) shows current ratio of 1.81 against its industry benchmark, while argenx (ARGX) has no reading this period.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
Min
0.10
ARGX
--

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.81

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
TMO
1.81
Min
0.10
Loading chart…
argenx (ARGX) vs. Thermo Fisher Scientific (TMO): ARGX does not report current ratio, so it has no value marker; TMO is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Debt / Equity (MRQ)

argenx (ARGX) at 0.01 keeps leverage in the lower quartile, while Thermo Fisher Scientific (TMO) at 0.75 sits in the higher-leverage quartile.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.01

Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
ARGX
0.01
Min
0.00

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.75

Max
1.42
TMO
0.75
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
argenx (ARGX) vs. Thermo Fisher Scientific (TMO): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for argenx (ARGX) and Thermo Fisher Scientific (TMO)
MetricARGXTMO
Current Ratio (MRQ)--1.81
Debt / Equity (MRQ)0.010.75
Net Debt / EBITDA-2.702.91

Dividends

Dividend Yield (TTM)

argenx (ARGX) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Thermo Fisher Scientific (TMO) reports a yield of 0.27%, ranking against industry peers normally.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ARGX
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.27%

TMO
0.27%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
argenx (ARGX) vs. Thermo Fisher Scientific (TMO): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

argenx (ARGX) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Thermo Fisher Scientific (TMO) reports a payout of 9.70%, ranking against industry peers normally.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ARGX
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

9.70%

TMO
9.70%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
argenx (ARGX) vs. Thermo Fisher Scientific (TMO): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for argenx (ARGX) and Thermo Fisher Scientific (TMO)
MetricARGXTMO
Dividend Yield (TTM)0.00%0.27%
Dividend Payout Ratio (TTM)0.00%9.70%

Valuation

P/E Ratio (TTM)

Both argenx (ARGX) at 32.12 and Thermo Fisher Scientific (TMO) at 36.64 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

32.12

Max
85.34
Q3
43.46
ARGX
32.12
Median
26.69
Q1
13.30
Min
0.07

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

36.64

Max
85.34
Q3
43.46
TMO
36.64
Median
26.69
Q1
13.30
Min
0.07
Loading chart…
argenx (ARGX) vs. Thermo Fisher Scientific (TMO): A comparison of their P/E ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/S Ratio (TTM)

On P/S ratio, both argenx (ARGX) at 9.86 and Thermo Fisher Scientific (TMO) at 5.44 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

9.86

Max
58.18
Q3
25.77
ARGX
9.86
Median
7.30
Q1
3.01
Min
0.01

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.44

Max
58.18
Q3
25.77
Median
7.30
TMO
5.44
Q1
3.01
Min
0.01
Loading chart…
argenx (ARGX) vs. Thermo Fisher Scientific (TMO): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

Thermo Fisher Scientific (TMO) at 4.70 sits near its industry’s typical P/B ratio, while argenx (ARGX) at 172.23 prices above its benchmark range — ARGX looks rich relative to book.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

172.23

ARGX
172.23
Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

4.70

Max
13.53
Q3
6.54
TMO
4.70
Median
3.25
Q1
1.69
Min
-5.59
Loading chart…
argenx (ARGX) vs. Thermo Fisher Scientific (TMO): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for argenx (ARGX) and Thermo Fisher Scientific (TMO)
MetricARGXTMO
P/E Ratio (TTM)32.1236.64
P/S Ratio (TTM)9.865.44
P/B Ratio (MRQ)172.234.70
Free Cash Flow Yield (TTM)--2.50%